BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34497089)

  • 1. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
    Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
    J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Fraszczyk E; Spijkerman AMW; Zhang Y; Brandmaier S; Day FR; Zhou L; Wackers P; Dollé MET; Bloks VW; Gào X; Gieger C; Kooner J; Kriebel J; Picavet HSJ; Rathmann W; Schöttker B; Loh M; Verschuren WMM; van Vliet-Ostaptchouk JV; Wareham NJ; Chambers JC; Ong KK; Grallert H; Brenner H; Luijten M; Snieder H
    Diabetologia; 2022 May; 65(5):763-776. PubMed ID: 35169870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.
    Sathyanarayanan A; Tanha HM; Mehta D; Nyholt DR
    Commun Biol; 2022 Jun; 5(1):594. PubMed ID: 35710732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
    Wu L; Yang Y; Guo X; Shu XO; Cai Q; Shu X; Li B; Tao R; Wu C; Nikas JB; Sun Y; Zhu J; Roobol MJ; Giles GG; Brenner H; John EM; Clements J; Grindedal EM; Park JY; Stanford JL; Kote-Jarai Z; Haiman CA; Eeles RA; Zheng W; Long J; ; ; ; ;
    Nat Commun; 2020 Aug; 11(1):3905. PubMed ID: 32764609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets.
    Olsson AH; Volkov P; Bacos K; Dayeh T; Hall E; Nilsson EA; Ladenvall C; Rönn T; Ling C
    PLoS Genet; 2014 Nov; 10(11):e1004735. PubMed ID: 25375650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
    BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate DNA methylation biomarkers related to Alzheimer's disease risk by integrating genome and blood methylome data.
    Sun Y; Zhu J; Yang Y; Zhang Z; Zhong H; Zeng G; Zhou D; Nowakowski RS; Long J; Wu C; Wu L
    Transl Psychiatry; 2023 Dec; 13(1):387. PubMed ID: 38092781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.
    Liu D; Zhu J; Zhou D; Nikas EG; Mitanis NT; Sun Y; Wu C; Mancuso N; Cox NJ; Wang L; Freedland SJ; Haiman CA; Gamazon ER; Nikas JB; Wu L
    Int J Cancer; 2022 Jan; 150(1):80-90. PubMed ID: 34520569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    Hillary RF; McCartney DL; Smith HM; Bernabeu E; Gadd DA; Chybowska AD; Cheng Y; Murphy L; Wrobel N; Campbell A; Walker RM; Hayward C; Evans KL; McIntosh AM; Marioni RE
    PLoS Med; 2023 Jul; 20(7):e1004247. PubMed ID: 37410739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; deFazio A; Dennis J; Doherty JA; Dörk T; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Onland-Moret NC; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2019 Feb; 79(3):505-517. PubMed ID: 30559148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls.
    Pedersen KS; Bamlet WR; Oberg AL; de Andrade M; Matsumoto ME; Tang H; Thibodeau SN; Petersen GM; Wang L
    PLoS One; 2011 Mar; 6(3):e18223. PubMed ID: 21455317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of Methylation of CpG Sites Associated With Systemic Lupus Erythematosus Subtypes in a Longitudinal Cohort.
    Lanata CM; Nititham J; Taylor KE; Solomon O; Chung SA; Blazer A; Trupin L; Katz P; Dall'Era M; Yazdany J; Sirota M; Barcellos LF; Criswell LA
    Arthritis Rheumatol; 2022 Oct; 74(10):1676-1686. PubMed ID: 35635730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenome-wide methylation study identified two novel CpGs associated with T2DM risk and a network of co-methylated CpGs capable of patient's classifications.
    Giri AK; Prasad G; Parekatt V; Rajashekar D; Tandon N; Bharadwaj D
    Hum Mol Genet; 2023 Aug; 32(16):2576-2586. PubMed ID: 37184252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
    Chung RH; Chiu YF; Wang WC; Hwu CM; Hung YJ; Lee IT; Chuang LM; Quertermous T; Rotter JI; Chen YI; Chang IS; Hsiung CA
    Diabetologia; 2021 Jul; 64(7):1613-1625. PubMed ID: 33842983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of diagnostic cytosine-phosphate-guanine biomarkers in patients with gestational diabetes mellitus
    Liu Y; Wang Z; Zhao L
    Gynecol Endocrinol; 2021 Sep; 37(9):857-862. PubMed ID: 34254540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.